Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Conflicted on These Healthcare Names: Merck & Company (MRK) and Alto Neuroscience, Inc. (ANRO)

Tipranks - Tipranks - Mon Apr 6, 11:46AM CDT

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Merck & Company (MRK) and Alto Neuroscience, Inc. (ANRO).

Easter Sale - 70% Off TipRanks

Merck & Company (MRK)

Bernstein analyst Courtney Breen maintained a Hold rating on Merck & Company on April 3. The company’s shares closed last Thursday at $120.87.

According to TipRanks.com, Breen is a 4-star analyst with an average return of 19.4% and a 84.1% success rate. Breen covers the Healthcare sector, focusing on stocks such as Bristol-Myers Squibb, Gilead Sciences, and Eli Lilly & Co. ;'>

Merck & Company has an analyst consensus of Moderate Buy, with a price target consensus of $132.74, a 10.3% upside from current levels. In a report issued on March 20, Citi also maintained a Hold rating on the stock with a $125.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Alto Neuroscience, Inc. (ANRO)

BTIG analyst Thomas Shrader maintained a Buy rating on Alto Neuroscience, Inc. on April 2 and set a price target of $28.00. The company’s shares closed last Thursday at $21.68.

According to TipRanks.com, Shrader is a 4-star analyst with an average return of 6.1% and a 39.9% success rate. Shrader covers the Healthcare sector, focusing on stocks such as Coya Therapeutics, Inc., Acumen Pharmaceuticals, and Arcturus Therapeutics. ;'>

Alto Neuroscience, Inc. has an analyst consensus of Strong Buy, with a price target consensus of $34.88, which is a 74.4% upside from current levels. In a report issued on March 18, Stifel Nicolaus also maintained a Buy rating on the stock with a $33.00 price target.

Read More on MRK:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).